Since Camkk2 promoter activity is restricted to the myeloid lineage in tumors (Fig. 1c), it seemed likely that CaMKK2 impacted tumor growth through its ability to regulate CD8+ T cell function secondary to activities within myeloid cells. This evidence concerns the gene CD8A and neoplasm.